These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3512409)

  • 1. Physiologic and pathologic manifestations of lymphokine action.
    Cohen S
    Hum Pathol; 1986 Feb; 17(2):112-21. PubMed ID: 3512409
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of lymphokine-dependent reactions.
    Cohen S
    Fed Proc; 1981 Jan; 40(1):51-3. PubMed ID: 7004913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms responsible for increased vascular permeability, fibrin deposits and chemotaxis in delayed hypersensitivity reactions.
    Sipka S; Szilágyi T
    Br J Dermatol; 1977 Oct; 97(4):469-70. PubMed ID: 588460
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphokines and cancer.
    Cavallo G
    G Batteriol Virol Immunol; 1990; 83(1-12):156-63. PubMed ID: 2133324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemical mediator, lymphokine, produced by activated lymphocytes].
    Morisawa S
    Nihon Rinsho; 1978; 36(5):937-43. PubMed ID: 353329
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological control of lymphokine function.
    Yoshida T; Cohen S
    Fed Proc; 1982 Jun; 41(8):2480-3. PubMed ID: 7044831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity and the inflammatory response.
    Cohen S; Winkler S
    J Periodontol; 1974 May; 45(5):348-50. PubMed ID: 4599517
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cell-mediated immunologic reactions. Cells and mediators].
    Pelletier M; Montplaisir S
    Union Med Can; 1979 Jun; 108(6):731-2. PubMed ID: 388786
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of lymphokine function.
    Cohen S; Yoshida T
    Ann N Y Acad Sci; 1979; 332():356-62. PubMed ID: 394637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the hematogenous cell infiltrate evoked by lymphokine injection with that of delayed hypersensitivity reactions.
    Franco MF; Kelly RH; Morley J
    Am J Pathol; 1978 Oct; 93(1):117-35. PubMed ID: 696800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The artificial granuloma 1: in vitro lymphokine production by pulmonary artificial hypersensitivity granulomas.
    Carrick L; Boros DL
    Clin Immunol Immunopathol; 1980 Nov; 17(3):415-26. PubMed ID: 7000405
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell mediated immunity and the inflammatory system.
    Cohen S
    Hum Pathol; 1976 May; 7(3):249-64. PubMed ID: 773808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercellular communication: role of soluble factors in cellular immune responses.
    Klesius PH
    J Am Vet Med Assoc; 1982 Nov; 181(10):1015-21. PubMed ID: 6816771
    [No Abstract]   [Full Text] [Related]  

  • 14. Abstracts from Fourth International Lymphokine Workshop. Molecular and cellular biology of lymphokines. October l7-21, 1984.
    Lymphokine Res; 1984; 3(4):229-85. PubMed ID: 6436585
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Jul; 117(1):66-72. PubMed ID: 1084371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity.
    Yoshida T; Cohen S
    J Immunol; 1974 Apr; 112(4):1540-7. PubMed ID: 4131167
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphokines (MIF) in the serum of patients with sarcoidosis and cutaneous granuloma annulare.
    Umbert P; Belcher RW; Winkelmann RK
    Br J Dermatol; 1976 Nov; 95(5):481-5. PubMed ID: 791335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Macrophage activation by macrophage activation factor and macrophage migration inhibitory factor].
    Onozaki K
    Nihon Saikingaku Zasshi; 1985 Sep; 40(5):811-7. PubMed ID: 3908741
    [No Abstract]   [Full Text] [Related]  

  • 19. Mediation of macrophage effector function by lymphokine.
    Poulter LW; Turk JL
    Agents Actions; 1976 Feb; 6(1-3):127-34. PubMed ID: 7933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro.
    Geczy CL; Hopper KE
    J Immunol; 1981 Mar; 126(3):1059-65. PubMed ID: 7462626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.